
Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303)
Author(s) -
D. Romanus,
H.L. Kindler,
L. Archer,
E. Basch,
D. Niedzwiecki,
J. Weeks,
D. Schrag
Publication year - 2012
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/d9wq-n731
Subject(s) - gemcitabine , pancreatic cancer , oncology , medicine , randomized controlled trial , cancer , quality of life (healthcare) , leukemia , nursing